Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · IEX Real-Time Price · USD
2.410
+0.030 (1.26%)
At close: May 17, 2024, 4:00 PM
2.480
+0.070 (2.90%)
After-hours: May 17, 2024, 7:51 PM EDT
Omega Therapeutics Market Cap
Omega Therapeutics has a market cap or net worth of $131.82 million as of May 17, 2024. Its market cap has decreased by -70.82% in one year.
Market Cap
131.82M
Enterprise Value
199.06M
1-Year Change
-70.82%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since the IPO on July 30, 2021, Omega Therapeutics's market cap has decreased from $792.62M to $131.82M, a decrease of -83.37%. That is a compound annual growth rate of -47.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 132.90M | 1.22% |
May 16, 2024 | 131.30M | 4.37% |
May 15, 2024 | 125.80M | -3.38% |
May 14, 2024 | 130.20M | 0.23% |
May 13, 2024 | 129.90M | 20.17% |
May 10, 2024 | 108.10M | -9.69% |
May 9, 2024 | 119.70M | 1.18% |
May 8, 2024 | 118.30M | -0.50% |
May 7, 2024 | 118.90M | -5.48% |
May 6, 2024 | 125.80M | -11.60% |
May 3, 2024 | 142.30M | -6.50% |
May 2, 2024 | 152.20M | 11.26% |
May 1, 2024 | 136.80M | 11.22% |
Apr 30, 2024 | 123.00M | -2.61% |
Apr 29, 2024 | 126.30M | 0.88% |
Apr 26, 2024 | 125.20M | -3.40% |
Apr 25, 2024 | 129.60M | 0.86% |
Apr 24, 2024 | 128.50M | -0.46% |
Apr 23, 2024 | 129.10M | -2.05% |
Apr 22, 2024 | 131.80M | -0.45% |
Apr 19, 2024 | 132.40M | -0.82% |
Apr 18, 2024 | 133.50M | -5.25% |
Apr 17, 2024 | 140.90M | 6.02% |
Apr 16, 2024 | 132.90M | -4.18% |
Apr 15, 2024 | 138.70M | -5.97% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vigil Neuroscience | 133.24M |
DBV Technologies | 133.19M |
aTyr Pharma | 132.50M |
Regulus Therapeutics | 132.24M |
Renovaro Biosciences | 131.77M |
PDS Biotechnology | 129.29M |
Adicet Bio | 128.60M |
Sangamo Therapeutics | 126.76M |